Apogee Therapeutics, Inc. APGE Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $451.8M+323% | $131.55M-7.2% | $107.91M-9.1% | $124.19M-59.6% | $106.92M-78.0% | ||
| $608.09M+49.6% | $598.64M+58.0% | $419.38M+3.0% | $381.23M+3.3% | $406.41M— | ||
| $13.91M+69.6% | $11.17M+23.2% | $12.81M+51.9% | $10.7M+90.3% | $8.2M+85.9% | ||
| $1.07B+106% | $741.36M+40.0% | $540.1M+1.1% | $516.12M-24.3% | $521.53M-36.4% | ||
| $5.28M-7.0% | $5.69M+190% | $6.03M+326% | $6.44M— | $5.68M— | ||
| $7.71M-33.0% | $8.69M-23.6% | $9.65M-20.5% | $10.59M— | $11.51M— | ||
| $8.52M+16.0% | $8.67M+1,641% | $8.74M+1,601% | $8.86M— | $7.34M— | ||
| $1.29B+81.1% | $937.13M+24.3% | $626.16M-19.3% | $657.77M-17.8% | $714.16M-13.3% | ||
| $8.51M-24.4% | $9.72M-25.9% | $9.57M-32.5% | $11.41M-13.4% | $11.26M-40.1% | ||
| $3.14M-21.1% | $3.5M+8.3% | $4.08M+42.3% | $4.03M— | $3.98M— | ||
| $32.95M0.0% | $27.91M-2.3% | $34.05M+4.4% | $31.55M+28.2% | $32.96M+52.9% | ||
| $4.91M-37.4% | $5.35M-37.8% | $5.77M-37.7% | $6.82M— | $7.84M— | ||
| $37.86M-7.2% | $33.25M-10.5% | $39.82M-4.9% | $38.37M+42.0% | $40.8M+83.9% | ||
| $1K0.0% | $1K0.0% | $1K— | $1K— | $1K— | ||
| $1.89B+83.1% | $1.46B+43.3% | $1.08B+11.1% | $1.05B+8.6% | $1.03B— | ||
| -$635.87M-76.0% | -$561.76M-83.6% | -$492.37M-106% | -$427.35M-125% | -$361.26M-132% | ||
| -$749K-170% | $1.08M+18.0% | $1.03M-68.6% | $685K+337% | $1.07M— | ||
| $1.29B+81.1% | $937.13M+24.3% | $626.16M-19.3% | $657.77M-17.8% | $714.16M-13.3% | ||
| $608.09M+49.6% | $598.64M+58.0% | $419.38M+3.0% | $381.23M+3.3% | $406.41M— | ||
| $8.52M+16.0% | $8.67M+1,641% | $8.74M+1,601% | $8.86M— | $7.34M— | ||
| $7.71M-33.0% | $8.69M-23.6% | $9.65M-20.5% | $10.59M— | $11.51M— | ||
| $7.71M-33.0% | $8.69M-23.6% | $9.65M-20.5% | $10.59M— | $11.51M— | ||
| $8.52M+16.0% | $8.67M+1,641% | $8.74M+1,601% | $8.86M— | $7.34M— | ||
| $7.71M-33.0% | $8.69M-23.6% | $9.65M-20.5% | $10.59M— | $11.51M— | ||
| $8.52M+16.0% | $8.67M+1,641% | $8.74M+1,601% | $8.86M— | $7.34M— | ||
| $28.58M— | $23.18M— | $29.59M— | —— | —— | ||
| $8.05M-31.9% | $8.85M-25.2% | $9.85M-18.8% | $10.85M— | $11.82M— | ||
| $1K0.0% | $1K0.0% | $1K— | $1K— | $1K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Apogee Therapeutics, Inc.'s total assets?
- Apogee Therapeutics, Inc. (APGE) holds $1.3B in total assets, up 81.1% year over year.
- How much cash does Apogee Therapeutics, Inc. have?
- Apogee Therapeutics, Inc. holds $451.8M in cash and equivalents.
- Can Apogee Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 32.59 — current assets exceed current liabilities.
- Where does Apogee Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Apogee Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.